Hutch News

Hutch News

Stories tagged 'Transplant and Immunotherapy'

First systematic study of infections after CAR T-cell therapy

“Benchmark” research could help reduce complications of emerging immunotherapy

Nov. 6, 2017 | by Susan Keown / Fred Hutch News Service

The first detailed study of infections after CAR T-cell therapy could help researchers improve the safety of this emerging type of genetically engineered cell therapy for cancer.

View story >


Dr. Stephanie Lee elected vice president of American Society of Hematology

Her one-year term will be followed by successive terms as president-elect and president

Nov. 1, 2017 | By Molly McElroy / Fred Hutch News Service

The American Society of Hematology has elected Dr. Stephanie Lee, a member of the Clinical Research Division at Fred Hutchinson Cancer Research Center, to be its vice president. The one-year term will begin after the 2017 ASH Annual Meeting Dec. 9–12 in Atlanta. It will be followed by successive one-year terms as president-elect and then as president. ASH announced the news Nov. 1.

View story >


Good News at Fred Hutch

Celebrating faculty and staff achievements

Oct. 26, 2017

Fred Hutch leader Dr. Gary Gilliland addressed lawmakers at a hearing to discuss NIH funding for biomedical research, particularly the role of a type of funding called facilities and administrative costs.

View story >


Science without borders

At Fred Hutch and other U.S. research centers, a global village works to cure cancer and other diseases

Oct. 16, 2017 | By Mary Engel / Fred Hutch Research Center

Fred Hutch, like other major U.S. cancer research centers, attracts top scientists from around the world working to cure cancer, HIV and other diseases

View story >


New insights into CAR T-cell therapy's potential side effects

Detailed study of cytokine release syndrome and neurologic toxicities could help make emerging cancer immunotherapies safer

Oct. 11, 2017 | By Fred Hutch staff

Detailed studies of two potential side effects of an emerging cancer immunotherapy could eventually help make this strategy, CAR T-cell therapy, safer for patients. The studies examined cytokine release syndrome and neurologic toxicities.

View story >


How techies in Washington state can help find cancer cures

The Hutch's Dr. Gary Gilliland speaks at GeekWire Summit highlighting innovations in the Northwest and beyond

Oct. 10, 2017 | By Susan Keown / Fred Hutch News Service

Washington state is known as the home for innovation in aviation and in coffee. But could it be known as the capital of cancer cures, too? That’s the question — and the challenge — that Fred Hutchinson Cancer Research Center President and Director Dr. Gary Gilliland posed to hundreds of tech industry and business leaders today at the 2017 GeekWire Summit in Seattle.

View story >



GIVE NOW &
SAVE LIVES

Support our quest for cures

Story Archive


Publications

Hutch Magazine
Our quarterly magazine

Annual Report
Fiscal year highlights

Science Spotlight
Monthly review of Center-authored papers



Fred Hutch News

        Get updates via email.